Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Beaten-Down Stocks to Watch Closely Next Year


Some biotech stocks are positioned to deliver outsized returns in a short period, but those that do generally come with a healthy amount of risk.

Consider, for instance, Editas Medicine (NASDAQ: EDIT) and BioXcel Therapeutics (NASDAQ: BTAI). These two small-cap biotechs are looking forward to developments that could send their shares soaring next year, and both are looking to execute strategies that could make them successful over the long run.

However, the potential downsides are massive, too. Let's consider why Editas Medicine and BioXcel Therapeutics are worth keeping an eye on right now, and whether the potential rewards of investing in these companies outweigh the risks. 

Continue reading


Source Fool.com

Like: 0
Share

Comments